Spanish Luxury Stock News

How Enagás earnings set the context for the stock Enagás (BME:ENG) has just reported half year 2026 results, with sales of €444.63 million and net income of €126.91 million, both lower than the same period a year earlier. Basic and diluted earnings per share from continuing operations were €0.49, compared with €0.68 a year ago. This gives investors fresh information to reassess how the stock’s current price reflects these figures. See our latest analysis for Enagás. Since the H1 2026 earnings...

Banco de Sabadell (BME:SAB) has reported Q2 2026 results with total revenue of €1,396 million and net income of €624 million, setting the tone for how the rest of the year may shape up for shareholders. The company has seen quarterly revenue move from €1,362 million in Q4 2025 to €1,046 million in Q1 2026 and then to €1,396 million in Q2 2026, while basic EPS tracked at €0.0776 in Q4 2025 and €0.0705 in Q1 2026. This gives investors a clearer view of how the top and bottom lines are pacing...

Grifols recently reported that the first patients have been dosed in two Phase 3 trials to expand U.S. labels for its flagship immunoglobulin therapies, GAMUNEX-C and XEMBIFY, targeting secondary immunodeficiency in certain blood cancers and chronic inflammatory demyelinating polyradiculoneuropathy. This push to broaden indications for existing plasma-derived products highlights how Grifols is trying to deepen its presence in complex, chronic immune-related conditions where immunoglobulin...

Atresmedia Corporación de Medios de Comunicación (BME:A3M) has drawn attention after reporting half year 2026 earnings, with sales of €458.38 million alongside lower net income and earnings per share compared with the previous year. See our latest analysis for Atresmedia Corporación de Medios de Comunicación. Atresmedia Corporación de Medios de Comunicación’s latest half year earnings have landed alongside a share price of €5.08, with a 1 day share price return of 2.83% and a 7 day share...

Investors in Laboratorios Farmaceuticos Rovi, S.A. ( BME:ROVI ) had a good week, as its shares rose 8.6% to close at...

Investors in Indra Sistemas, S.A. ( BME:IDR ) had a good week, as its shares rose 8.9% to close at €53.36 following the...

Vidrala, S.A. ( BME:VID ) shareholders are probably feeling a little disappointed, since its shares fell 5.3% to €86.00...

Tubacex (BME:TUB) has released its Q2 2026 results with revenue of €170.6 million and a net loss of €0.6 million, setting a mixed headline for investors watching the stock around €3.12. The company has seen quarterly revenue move from €180.8 million in Q2 2025 to €170.6 million in Q2 2026, while net income shifted from a profit of €4.4 million to a small loss of €0.6 million over the same period, and EPS in Q2 2025 was €0.04 compared with €0.01 in Q1 2026. Overall, Tubacex is showing solid...

Almirall (BME:ALM) has put fresh numbers on the table for Q2 2026, reporting revenue of €313.2 million and net income of €24.3 million, alongside trailing twelve month EPS of €0.28 on revenue of €1.16 billion and net income of €59.1 million. The company has seen revenue move from €262.2 million in Q3 2025 to €288.9 million in Q4 2025, €292.4 million in Q1 2026 and now €313.2 million in Q2 2026, with quarterly net income shifting from €12.5 million to €7.1 million, €15.3 million and €24.3...

Why Bankinter's Latest Earnings Matter for Investors Bankinter (BME:BKT) has attracted fresh attention after reporting half year 2026 results, with net interest income of €1,173.67 million and net income of €605.26 million, both above the prior year period. See our latest analysis for Bankinter. Since those half year figures, Bankinter's share price has gained 10.97% over the past month and 15.77% over the last quarter, while the 1 year total shareholder return of 37.12% and very large 5 year...

It's been a good week for Naturgy Energy Group, S.A. ( BME:NTGY ) shareholders, because the company has just released...

The new US tariff regime under Section 301 is quietly reshaping the playing field for global exporters, and European stocks are right in the middle of it. With lower duties for key countries like France, the UK, Germany, Spain, Belgium, and Italy, and higher rates for rivals such as Brazil, some European exporters now sit in a more favorable position in US trade. This article looks at how that shift connects to large European companies on our European Exporters screener and reveals 3 stocks...

CIE Automotive (BME:CIE) has drawn attention after reporting half year 2026 earnings, with sales, revenue, net income and earnings per share all higher than the figures reported a year earlier. See our latest analysis for CIE Automotive. Despite the stronger half year figures, CIE Automotive’s recent share price performance has been weak, with the stock at €25.8 and a year to date share price decline of 14.99%. However, the 5 year total shareholder return of 17.34% points to a more resilient...

Repsol’s share price has delivered very strong gains over the past five years, yet there is a clear split in what current valuation tools are signalling, with the Discounted Cash Flow (DCF) intrinsic value estimate pointing to sizeable upside while market based multiples suggest the stock is closer to expensive territory. The stock has returned 256.9% over five years, which raises the bar for any further upside to be supported by fundamentals. Recent profit strength and expansion in areas...

Indra Sistemas (BME:IDR) has put solid headline figures on the table for Q2 2026, with revenue of about €1.9b, basic EPS of €0.81 and net income of €143.1m, giving investors plenty to weigh as earnings season rolls on. The company has seen revenue move from €1.29b in Q2 2025 to €1.9b in Q2 2026, while quarterly basic EPS has shifted from €0.88 to €0.81 over the same period, framing a mixed picture on the top and bottom lines. With trailing net profit margin sitting below last year’s level,...

Laboratorios Farmaceuticos Rovi (BME:ROVI) has released its Q2 2026 results with revenue of €191.7 million and net income of €75.0 million, set against trailing 12 month revenue of €773.1 million, net income of €185.2 million, and Basic EPS of €3.61 that reflects a 40% year over year earnings increase. Over recent quarters the company has seen revenue move from €159.7 million in Q2 2025 to €210.5 million in Q3 2025, €218.4 million in Q4 2025, €152.5 million in Q1 2026 and now €191.7 million...

Banco Santander (BME:SAN) has posted its Q2 2026 numbers with revenue of about €12.1 billion and net income from continuing operations of €3.7 billion, setting the tone for a results season where profitability stays front and center. The bank has seen quarterly revenue move from €11.6 billion in Q1 2025 to €12.5 billion in Q4 2025 and €12.1 billion in Q1 2026, while basic EPS shifted from €0.19 in Q1 2025 to €0.20 in Q4 2025 and €0.23 in Q1 2026, giving investors a clear run-up of the top and...

Repsol (BME:REP) is back in focus after BMW Group and Toyota Motor Europe began a six month pilot in Spain using its Nexa 95 renewable gasoline, testing how fully renewable fuel fits into real world transport. See our latest analysis for Repsol. The Nexa 95 pilot comes at a time when Repsol’s share price has been strong, with a 30 day share price return of 17.8% and year to date share price return of 55.27%, alongside a 1 year total shareholder return of 101.92% that points to solid momentum...

Naturgy Energy Group (BME:NTGY) has reported Q2 2026 revenue of about €5.0 billion and net income, excluding extraordinary items, of €685 million, with the shares trading around €29.48 ahead of the market’s full verdict on these numbers. The company has seen quarterly revenue move between about €4.6 billion and €5.5 billion over the past six reported periods. Trailing twelve month net income, excluding extra items, stands at €2.1 billion, alongside trailing EPS of €2.21 as of Q1 2026, which...

Talgo (BME:TLGO) has just posted its H1 2026 scorecard, with revenue of €349.3 million and a loss of €34.2 million, translating to EPS of €0.27, while the trailing 12 month view shows revenue of €726.3 million and a loss of €59.9 million, or EPS of €0.46. The company has seen revenue move from €324.8 million and EPS of €0.99 in H2 2024 to €271.8 million and EPS of €0.52 in H1 2025, before reaching the latest H2 2025 and trailing 12 month levels. This gives investors a clearer sense of how the...

Why Banco Santander’s latest half year earnings matter for investors Banco Santander (BME:SAN) has become a focus for investors after reporting half year 2026 net income of €8,973 million, compared with €6,833 million for the same period a year earlier. See our latest analysis for Banco Santander. At a share price of €11.906, Banco Santander has moved higher over the year, with a 16.13% year to date share price return and a 68.07% total shareholder return over 12 months. This suggests...

The European market has experienced a mixed performance recently, with the pan-European STOXX Europe 600 Index remaining relatively stable amid global tech stock volatility and geopolitical tensions. As investors navigate these uncertain times, dividend stocks can offer a more stable income stream, making them an attractive option for those seeking to balance growth with consistent returns in their portfolios.

Why the Coravel launch matters for ACS Actividades de Construcción y Servicios stock ACS Actividades de Construcción y Servicios (BME:ACS) is in focus after its Coravel data center joint venture with Global Infrastructure Partners secured a first major hyperscaler contract and formally launched its global platform. The agreement covers roughly 140 megawatts of IT load at Coravel's Dallas Fort Worth campus, with options for about 100 megawatts of additional capacity. Turner will build the...

Grifols (BME:GRF) stock is back in focus after the company dosed the first patients in two Phase 3 trials designed to expand U.S. labels for key immunoglobulin therapies GAMUNEX-C and XEMBIFY. See our latest analysis for Grifols. Despite the positive reaction around the Phase 3 trial dosing, with a 1-day share price return of 3.72% and 7-day share price return of 5.68%, Grifols’ momentum is building from a low base, as the year to date share price return is down 15.89% and the 1-year total...